Discover Who You’ll Meet at the Novel CNS Biomarkers Summit Europe
Bringing together an exclusive community of 60+ senior biomarker, translational medicine, neuroscience, precision medicine, bioanalytical and clinical development leaders dedicated to advancing the future of CNS drug development, find out who you'll meet at the Novel CNS Biomarkers Summit Europe by downloading our audience preview.
Why This Audience Matters
Whether you're looking to validate novel biomarkers, strengthen patient stratification strategies, explore multimodal approaches, or generate regulatory-ready evidence, you'll be surrounded by professionals actively tackling the same challenges. With dedicated networking sessions, interactive discussions and workshops, the Novel CNS Biomarkers Summit Europe is designed to facilitate high-value conversations that continue long after the event concludes.
Explore the Agenda
Discover the latest case studies and practical strategies shaping the future of CNS biomarker development from Lundbeck, Roche, UCB & more.
Partner With Us
Position your brand alongside Europe's leading biomarker innovators and connect with decision-makers actively seeking new technologies and partners.
Join Biopharma Experts
Exchange ideas with biomarker, translational medicine and clinical development leaders tackling the biggest challenges in neurodegenerative drug development.